For the year ending 2025-12-31, DSGN has $226,203K in assets. $13,700K in debts. $16,856K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 16,856 | |||
| Investment securities | 202,989 | |||
| Prepaid expenses and other current assets | 3,939 | |||
| Total current assets | 223,784 | |||
| Property and equipment | 3,245 | |||
| Less accumulated depreciation | 2,264 | |||
| Property and equipment, net | 981 | |||
| Right-of-use asset, related party | 1,438 | |||
| Other assets | 0 | |||
| Total assets | 226,203 | |||
| Accounts payable | 2,312 | |||
| Accrued expenses and other current liabilities (including related party amounts of 890 and 800, respectively) | 10,743 | |||
| Total current liabilities | 13,055 | |||
| Operating lease liability, net, related party | 645 | |||
| Total liabilities | 13,700 | |||
| Common stock 0.0001 par value 200,000,000 shares authorized, 60,398,051 and 56,754,341 shares issued and outstanding at december 31, 2025 and 2024, respectively | 6 | |||
| Additional paid-in capital | 509,100 | |||
| Accumulated deficit | -297,006 | |||
| Accumulated other comprehensive income | 403 | |||
| Total stockholders' equity | 212,503 | |||
| Total liabilities and stockholders' equity | 226,203 | |||
Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN)